SPHK1 and urinary bladder cancer: These findings not only unveil a new functional role of PD-L2 regulated by S1PR/Akt/β-catenin signaling network in facilitating bladder cancer metastases, but also identify SPHK1 as a potential therapeutic target for preventing bladder cancer progression.